BNF:

8.2.4/8.3

Status:

Red

Decision Date:

August 2011

Comments

RED:^1,2,3 NICE TA228 Thalidomide: a recommended option for specified people with multiple myeloma

NHS England drug. To be used in line with NHS England commissioning intentions

Red Drug Classifications

• 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
• 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
• 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)

search again